The startup was co-founded in 2017 by Younger and CTO Randolph Lopez, using the technology they helped to develop while graduate researchers at the UW. A-Alpha Bio employs 45 people, up from 13 ...

BOSTON, September 06, 2024--PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies ...

Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflamma ...

SAN DIEGO, May 07, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...

Superior Cedex Bio Analyzer Data Quality. An established analyzer using membrane-based technology was compared to the Cedex Bio Analyzer using reference standards (see glucose, lactate, and ...

Gennao Bio is a genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing its proprietary, non-viral gene monoclonal antibody (GMAB) platform technology.

Pivot Bio, a startup using microbes to replace synthetic fertilizer, raises $430 mln. By Jane Lee. July 19, 2021 2:45 PM UTC Updated July 19, 2021 ... Access unmatched financial data, ...

Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands out and TIL stock is a buy.

Rejuvenate Bio is a gene therapy startup that seeks to reverse aging. In response to emailed questions, CEO and Co-founder Daniel Oliver talked about how he and his co-founder started the company ...

(RTTNews) - Palisade Bio, Inc. (PALI), a clinical-stage biopharmaceutical company, Tuesday reported positive topline data from its Phase 1 studies of PALI-2108, which is being developed for the ...